Clearbridge Investments, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Clearbridge Investments, LLC

$123 Billion
Q3 2024

A detailed history of Clearbridge Investments, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Clearbridge Investments, LLC holds 2,426,977 shares of RARE stock, worth $110 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,426,977

Previous 2,353,804 3.11%

Holding current value

$110 Million

Previous $96.7 Million 39.36%

% of portfolio

0.11%

Previous 0.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$40.21 - $59.36 $2.94 Million - $4.34 Million	73,173 Added 3.11%	2,426,977 $135 Million
Q2 2024 Aug 14, 2024	SELL	$37.42 - $51.61 $1.76 Million - $2.43 Million	-47,050 Reduced 1.96%	2,353,804 $96.7 Million
Q1 2024 May 13, 2024	BUY	$43.02 - $53.69 $746,913 - $932,165	17,362 Added 0.73%	2,400,854 $112 Million
Q4 2023 Feb 09, 2024	BUY	$31.73 - $49.19 $2.85 Million - $4.42 Million	89,922 Added 3.92%	2,383,492 $114 Million
Q3 2023 Nov 13, 2023	SELL	$34.92 - $46.66 $16.4 Million - $21.9 Million	-469,676 Reduced 17.0%	2,293,570 $81.8 Million
Q2 2023 Aug 11, 2023	BUY	$37.35 - $52.15 $2.32 Million - $3.24 Million	62,169 Added 2.3%	2,763,246 $127 Million
Q1 2023 May 12, 2023	BUY	$36.99 - $48.71 $245,428 - $323,190	6,635 Added 0.25%	2,701,077 $108 Million
Q4 2022 Feb 10, 2023	SELL	$33.72 - $46.33 $2.31 Million - $3.17 Million	-68,380 Reduced 2.48%	2,694,442 $125 Million
Q3 2022 Nov 14, 2022	SELL	$39.96 - $66.14 $2.97 Million - $4.92 Million	-74,321 Reduced 2.62%	2,762,822 $114 Million
Q2 2022 Aug 11, 2022	SELL	$45.8 - $85.4 $1.23 Million - $2.29 Million	-26,778 Reduced 0.94%	2,837,143 $169 Million
Q1 2022 May 13, 2022	BUY	$62.2 - $84.4 $5.29 Million - $7.18 Million	85,062 Added 3.06%	2,863,921 $208 Million
Q4 2021 Feb 11, 2022	BUY	$73.71 - $87.86 $30.5 Million - $36.3 Million	413,238 Added 17.47%	2,778,859 $234 Million
Q3 2021 Nov 12, 2021	SELL	$77.92 - $102.4 $381,730 - $501,657	-4,899 Reduced 0.21%	2,365,621 $213 Million
Q2 2021 Aug 13, 2021	BUY	$92.19 - $115.71 $43.1 Million - $54.1 Million	467,125 Added 24.54%	2,370,520 $226 Million
Q1 2021 May 13, 2021	BUY	$106.9 - $167.73 $3 Million - $4.71 Million	28,078 Added 1.5%	1,903,395 $217 Million
Q4 2020 Feb 10, 2021	BUY	$84.4 - $177.39 $8.13 Million - $17.1 Million	96,339 Added 5.42%	1,875,317 $260 Million
Q3 2020 Nov 12, 2020	BUY	$72.98 - $90.0 $906,119 - $1.12 Million	12,416 Added 0.7%	1,778,978 $146 Million
Q2 2020 Aug 14, 2020	BUY	$46.91 - $78.22 $25.2 Million - $42 Million	537,252 Added 43.7%	1,766,562 $138 Million
Q1 2020 May 15, 2020	BUY	$33.8 - $62.9 $1.81 Million - $3.37 Million	53,536 Added 4.55%	1,229,310 $54.6 Million
Q4 2019 Feb 14, 2020	SELL	$36.08 - $45.83 $7.43 Million - $9.44 Million	-206,003 Reduced 14.91%	1,175,774 $50.7 Million
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $15.9 Million - $23.6 Million	373,904 Added 37.1%	1,381,777 $59.1 Million
Q2 2019 Aug 14, 2019	SELL	$54.93 - $74.36 $296,622 - $401,544	-5,400 Reduced 0.53%	1,007,873 $0
Q1 2019 May 15, 2019	BUY	$39.87 - $69.36 $129,059 - $224,518	3,237 Added 0.32%	1,013,273 $70.3 Million
Q4 2018 Feb 14, 2019	BUY	$38.89 - $77.3 $6,377 - $12,677	164 Added 0.02%	1,010,036 $43.9 Million
Q3 2018 Nov 14, 2018	BUY	$71.81 - $90.15 $3.84 Million - $4.82 Million	53,460 Added 5.59%	1,009,872 $77.1 Million
Q2 2018 Aug 14, 2018	BUY	$48.54 - $85.31 $7.85 Million - $13.8 Million	161,824 Added 20.37%	956,412 $73.5 Million
Q1 2018 May 15, 2018	BUY	$44.33 - $58.52 $35 Million - $46.2 Million	790,168 Added 17877.1%	794,588 $40.5 Million
Q4 2017 Feb 14, 2018	SELL	$43.54 - $57.32 $217 - $286	-5 Reduced 0.11%	4,420 $205,000
Q3 2017 Nov 14, 2017	BUY	$49.79 - $66.32 $1,394 - $1,856	28 Added 0.64%	4,425 $236,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,397	4,397 $273,000

Others Institutions Holding RARE

# of Institutions

326

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.18B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account

Clearbridge Investments, LLC Ultragenyx Pharmaceutical Inc. Transaction History